Skip to main
INMD

Inmode Ltd (INMD) Stock Forecast & Price Target

Inmode Ltd (INMD) Analyst Ratings

Based on 4 analyst ratings
Hold
Strong Buy 0%
Buy 25%
Hold 75%
Sell 0%
Strong Sell 0%

Bulls say

InMode Ltd demonstrated robust growth in the second quarter of 2025, achieving sales of 971 systems and increasing its global installed base to approximately 28,855 units, which includes around 12,347 units in the U.S., reflecting a 3.4% rise from the previous quarter. The company reported an impressive operating margin of 27.5%, surpassing expectations and showing a year-over-year improvement of 40 basis points. Additionally, the domestic sales of $49.7 million represent a significant positive turnaround, with a growth rate of 9% compared to a decline of 7% in the prior quarter, indicating an upward trend in consumer and physician interest in aesthetic treatments.

Bears say

InMode Ltd faces a negative outlook primarily due to expected contraction in gross margins, which may hinder overall profitability despite its historically high margins relative to the med tech sector. The company's earnings per share (EPS) growth is projected to lag behind revenue growth, indicating potential challenges in translating sales into profit. Furthermore, the bear case scenario predicts a revenue compound annual growth rate (CAGR) of less than 5% over the next few years, driven by weaker growth from existing products and slower adoption rates for new offerings.

Inmode Ltd (INMD) has been analyzed by 4 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 25% recommend Buy, 75% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Inmode Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Inmode Ltd (INMD) Forecast

Analysts have given Inmode Ltd (INMD) a Hold based on their latest research and market trends.

According to 4 analysts, Inmode Ltd (INMD) has a Hold consensus rating as of Jan 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Inmode Ltd (INMD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.